Physician profile
Katelyn Dolbec
NPI 1518310697
$2,064.18
in general payments reported to CMS, 2019-2025
35 companies · $660 in 2025
The $660 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14.41 · 2020: $21.30 · 2021: $149 · 2022: $286 · 2023: $465 · 2024: $468 · 2025: $660.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,594.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,593.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $332.51 | 2024-2025 | Synfix Evolution, Fibergraft Bg Morsels, Fibergraft Aeridyan Matrix |
| Jazz Pharmaceuticals INC. | $269.41 | 2023-2025 | |
| Biogen, INC. | $119.39 | 2021-2025 | Vumerity, Leqembi |
| Abbvie INC. | $117.80 | 2022-2025 | Ubrelvy |
| Amneal Pharmaceuticals LLC | $115.65 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $113.35 | 2022-2024 | Gammagard, Hyqvia |
| Ucb, INC. | $94.90 | 2023-2025 | Fintepla, Briviact |
| Teva Pharmaceuticals USA, INC. | $76.00 | 2024-2025 | Austedo Xr, Austedo Xr |
| Amgen INC. | $72.39 | 2022-2025 | Aimovig, Uplizna |
| Lilly USA, LLC | $68.30 | 2022-2025 | Emgality, Kisunla, Reyvow |
| Otsuka America Pharmaceutical, INC. | $57.00 | 2023-2024 | Nuedexta, Rexulti |
| Grifols USA, LLC | $48.76 | 2025 | Gamunex-C |
| Acadia Pharmaceuticals INC | $44.00 | 2021-2024 | Nuplazid |
| Tg Therapeutics, INC. | $42.93 | 2025 | |
| Pfizer INC. | $39.42 | 2023 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $38.05 | 2019-2023 | |
| Alexion Pharmaceuticals, INC. | $37.88 | 2023-2024 | Ultomiris |
| Csl Behring | $37.04 | 2023-2024 | Hizentra |
| Janssen Pharmaceuticals, INC | $36.00 | 2021 | |
| Kyowa Kirin, INC. | $34.35 | 2021-2022 | |
| Emd Serono, INC. | $26.10 | 2025 | |
| Genentech USA, INC. | $26.06 | 2025 | Ocrevus Zunovo |
| Mayne Pharma Commercial LLC | $21.30 | 2020 | |
| Neurelis, INC. | $19.38 | 2025 | Valtoco |
| Mdd US Operations, LLC | $19.18 | 2024 | Gocovri |
| Biohaven Pharmaceutical Holding Company LTD. | $18.66 | 2022 | |
| Argenx US, INC. | $17.86 | 2025 | Vyvgart |
| Corium, LLC | $17.20 | 2023 | Adlarity |
| Vanda Pharmaceuticals INC. | $16.54 | 2025 | Ponvory |
| Abbott Laboratories | $16.42 | 2023 | Amplatzer Talisman |
| Hospira, INC. | $15.55 | 2024 | |
| Supernus Pharmaceuticals, INC. | $15.21 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $13.57 | 2021 | |
| Impel Pharmaceuticals INC. | $13.38 | 2023 | Trudhesa |
| Banner Life Sciences, LLC | $12.64 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katelyn Dolbec listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.